. Author manuscript; available in PMC: 2015 Feb 19.

Published in final edited form as: J Nucl Cardiol. 2011 Mar 30;18(3):443–450. doi: 10.1007/s12350-011-9369-9

Table 1.

Description of study groups

Transplantation route	Transplanted cell number	Cardiac retention	Lung retention
Intra-myocardial injection
Permanent ligation (PL), n = 15 Cell transplantation immediately following ligation	2 × 10⁶	22.9% ± 5.2%	28.5% ± 5.0%
Acute ischemia-reperfusion (AI-RM), n = 17 Ischemia for 45 minutes followed by reperfusion and immediate cell transplantation	2 × 10⁶	12.0% ± 3.9%	39.9% ± 9.3%
Normal (NL), n = 10 Cell transplantation without infarction	2 × 10⁶	13.6% ± 2.3%	43.3% ± 5.6%
Chronic ischemia-reperfusion (CI-R), n = 13 Ischemia for 45 minutes followed by reperfusion; cell transplantation 30 days after reperfusion	2 × 10⁶	9.9 ± 2.8	20.2% ± 9.3%
Intracoronary (intra-cavitary) injection
Acute ischemia-reperfusion (AI-RC), n = 5 Ischemia for 45 minutes followed by reperfusion and immediate cell transplantation	1 × 10⁶	15.4% ± 5.5%	19.9% ± 5.6%
Intravenous injection
Acute ischemia-reperfusion (AI-RV), n = 10 Ischemia for 45 minutes followed by reperfusion and immediate cell transplantation	5 × 10⁶	0.8% ± 1.06%	55.1% ± 9.3%